Back to top

Psychedelic: Clearmind reports safety findings for CMND-100

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on safety results, earnings and anal...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

COMPASS Pathways PLC Sponsored ADR (CMPS)

Definium Therapeutics, Inc. (DFTX)

GH Research PLC (GHRS)

Cybin Inc. (HELP)